Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FDL59
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,114
Award facts
- Contract value 100% obligated
- $43,113.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $43,113.50 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units). DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform delivery from its Park Ridge location with an ultimate completion date of September 8, 2025. This delivery order was awarded without a set-aside designation on September 5, 2025. Xtandi is a prescription medication used in oncology treatment, consistent with the company's established portfolio of specialty pharmaceutical products delivered to federal healthcare facilities.
This award represents a delivery order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.9 billion vehicle valid through November 2026. Through this master contract, the Defense Logistics Agency can issue firm fixed-price delivery orders for comprehensive pharmaceutical supplies supporting military health facilities worldwide. DMS Pharmaceutical Group's role as a crucial supplier in the federal pharmaceutical supply chain positions it to meet the Department of Defense's ongoing medication and medical supply requirements across its healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DB25FDL59?
SPE2DB25FDL59 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FDL59 worth?
The government has obligated $43,114 on SPE2DB25FDL59.
Is contract SPE2DB25FDL59 an order under another contract?
Yes. SPE2DB25FDL59 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDL59 competed?
The extent of competition for SPE2DB25FDL59 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award